11
Views
4
CrossRef citations to date
0
Altmetric
Special Report

Review of models used to predict the future numbers of individuals with severe hepatitis C disease: therapeutic and cost implications

, &
Pages 627-639 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jonathan Shepherd & Jeremy Jones. (2007) A systematic review of the cost–effectiveness of peginterferon alfa-2b in the treatment of chronic hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research 7:6, pages 577-595.
Read now

Articles from other publishers (3)

Bo Fu, Wenbin Wang & Xin Shi. (2011) Impact of delayed diagnosis time in estimating progression rates to hepatitis C virus-related cirrhosis and death. Statistical Methods in Medical Research 24:6, pages 693-710.
Crossref
Scott A. McDonald, Maznah Dahlui, Rosmawati Mohamed, Herlianna Naning, Fatiha Hana Shabaruddin & Adeeba Kamarulzaman. (2015) Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia. PLOS ONE 10:6, pages e0128091.
Crossref
Scott A McDonaldSharon J Hutchinson, Sheila M Bird, Peter R Mills, John Dillon, Mick Bloor, Chris Robertson, Martin Donaghy, Peter Hayes & Lesley Graham. (2008) A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Statistical Methods in Medical Research 18:3, pages 271-283.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.